Partnership Agreement / Nonacus
Massive Bioinformatics is happy to announce a collaboration between our firm and Nonacus
to work on groundbreaking projects in the field of genomic healthcare. We believe this
collaboration will promote innovation, dependability, and the speed of discovery in the
biological and medical sciences by utilizing Nonacus’ non-invasive cfDNA solutions and cancer
panels” stated Ibrahim H. Miraloglu, General Manager at Massive Bioinformatics.
About Nonacus:
Nonacus is a leading provider of genetic testing products based in Birmingham, UK. The
company works with scientists and clinicians to provide a complete workflow for primary
tumour and liquid biopsy analysis with the ultimate goal of enabling enhanced care through
earlier diagnosis, treatment stratification and monitoring.